Saturday 17 October 2026
Export OMCL’s income statement to Excel — free account
Omnicell, Inc.
OMCL Healthcare Health Information Services
Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024. In the quarter to June 2026, revenue grew 7.45%, EPS grew 341.7%, free cash flow grew 107.9% and total debt fell 50.8%, each against the same quarter a year earlier.
35.39
0.56
−1.56%
Follow OMCL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 4 | 5 | 6 | 4 | 8 | 8 | 4 | 4 |
P/E ratio |
1,132.50 | 164.89 | 0.00 | 368.14 | 100.80 | 155.87 | 55.22 | 63.79 | 86.77 | 128.36 |
P/S ratio |
1.76 | 1.84 | 1.47 | 1.77 | 6.93 | 5.73 | 3.78 | 3.05 | 2.60 | 1.79 |
Altman Z-Score |
2.69 | 2.30 | 1.98 | 2.32 | 5.58 | 4.72 | 6.60 | 4.92 | 3.49 | 2.60 |
P/FCF ratio |
30.02 | 15.19 | 13.39 | 134.28 | 45.22 | 39.01 | 40.65 | 48.46 | 0.00 | 59.98 |
Altman Z″-Score (non-manufacturers) |
3.07 | 2.76 | 3.29 | 3.01 | 1.76 | 3.82 | 4.65 | 3.82 | 2.80 | 2.35 |
P/Operating CF |
68.60 | 36.40 | 43.94 | 27.85 | 131.55 | 66.85 | 97.31 | 50.64 | 443.24 | 52.11 |
Beneish M-Score |
(2.85) | (2.74) | (3.01) | (2.43) | (2.56) | (3.27) | (2.64) | (2.70) | (2.16) | (2.54) |
P/B ratio |
1.69 | 1.65 | 1.42 | 2.02 | 6.84 | 5.28 | 4.01 | 3.54 | 3.35 | 2.88 |
Price to Tangible BV |
6.43 | 6.40 | 6.98 | 14.96 | 60.26 | 17.04 | 8.83 | 12.01 | 38.27 | 0.00 |
EV/Sales |
1.88 | 1.82 | 1.57 | 1.96 | 7.09 | 5.72 | 3.70 | 3.16 | 2.85 | 2.07 |
EV/EBITDA |
23.59 | 21.53 | 27.66 | 25.10 | 40.84 | 44.98 | 22.96 | 25.39 | 31.65 | 17.74 |
EV/Operating CF |
17.50 | 10.77 | 9.94 | 32.60 | 34.61 | 27.46 | 22.90 | 23.94 | 81.87 | 28.93 |
EV/FCF |
32.12 | 14.98 | 14.28 | 148.79 | 46.25 | 38.96 | 39.85 | 50.19 | (356.25) | 69.61 |
Quick Ratio |
0.87 | 1.05 | 1.96 | 1.47 | 0.67 | 2.45 | 1.46 | 1.29 | 1.08 | 1.13 |
Current Ratio |
1.43 | 1.37 | 2.52 | 2.06 | 0.89 | 3.00 | 2.04 | 1.94 | 1.72 | 1.74 |
Net Debt/EBITDA |
(0.31) | (0.30) | 1.56 | 2.45 | 0.91 | (0.06) | (0.46) | 0.70 | 2.77 | 2.45 |
Debt/Assets |
8.49% | 16.06% | 25.58% | 26.13% | 24.65% | 26.26% | 4.84% | 12.52% | 20.67% | 27.18% |
Debt/Equity |
0.14 | 0.27 | 0.48 | 0.51 | 0.46 | 0.50 | 0.07 | 0.20 | 0.38 | 0.59 |
Asset Turnover |
0.58 | 0.51 | 0.52 | 0.60 | 0.57 | 0.58 | 0.77 | 0.75 | 0.73 | 0.92 |
Operating CF/Net income |
62.04 | 14.98 | (8.89) | 13.77 | 2.98 | 5.77 | 2.36 | 2.76 | 0.81 | 5.11 |
Capex/Depreciation |
(0.65) | (0.56) | (0.55) | (0.59) | (0.55) | (0.70) | (0.93) | (1.01) | (0.58) | (0.49) |
Interest Coverage |
— | — | — | — | — | — | 17.73 | 5.06 | 1.68 | — |
| 0.17% | 1.03% | (1.76%) | 0.50% | 7.36% | 3.55% | 8.05% | 6.12% | 6.19% | 2.34% | |
| 0.10% | 0.58% | (0.92%) | 0.26% | 3.92% | 2.10% | 5.28% | 3.60% | 3.13% | 1.29% | |
ROIC |
0.27% | 0.02% | (1.69%) | (0.11%) | 4.22% | 2.31% | 6.29% | 3.71% | 0.95% | 2.12% |
Return on Tangible Assets |
0.63% | 3.77% | (3.05%) | 1.03% | (320.17%) | 5.26% | 20.41% | 15.46% | 16.09% | 5.53% |
Average Days of Receivables |
66.80 | 84.14 | 80.19 | 84.34 | 77.67 | 77.78 | 88.85 | 90.98 | 97.33 | 78.83 |
Research and Development Expense of Revenue |
7.48% | 8.13% | 8.47% | 8.10% | 6.69% | 7.86% | 7.65% | 8.24% | 9.26% | 8.31% |
Selling, General and Administrative Expense of Revenue |
34.57% | 34.19% | 37.89% | 37.53% | 34.40% | 34.48% | 32.32% | 33.42% | 33.88% | 34.18% |
Intangible Assets out of Total Assets |
0.46 | 0.44 | 0.43 | 0.44 | 0.47 | 0.37 | 0.37 | 0.44 | 0.50 | 0.55 |
Share Based Compensation of Revenue |
3.76% | 3.53% | 4.82% | 5.27% | 4.70% | 5.01% | 3.80% | 3.67% | 3.07% | 2.80% |
Graham Net Nets |
(0.03) | (0.03) | (0.07) | (0.09) | (0.03) | (0.01) | 0.03 | 0.00 | (0.06) | (0.15) |
Graham Number |
4.91 | 12.81 | 0.00 | 8.95 | 32.59 | 19.84 | 26.06 | 19.34 | 13.78 | 8.48 |
Earnings Yield |
0.09% | 0.61% | (1.21%) | 0.27% | 0.99% | 0.64% | 1.81% | 1.57% | 1.15% | 0.78% |
Free Cash Flow Yield |
3.33% | 6.58% | 7.47% | 0.74% | 2.21% | 2.56% | 2.46% | 2.06% | (0.31%) | 1.67% |
Revenue per Share |
25.78 | 24.15 | 25.37 | 29.19 | 26.04 | 20.95 | 21.63 | 20.06 | 19.01 | 19.25 |
Operating CF per Share |
2.77 | 4.08 | 4.01 | 1.75 | 5.33 | 4.36 | 3.50 | 2.65 | 0.66 | 1.38 |
Capex per Share |
(1.26) | (1.15) | (1.22) | (1.37) | (1.34) | (1.29) | (1.49) | (1.39) | (0.81) | (0.81) |
Free Cash Flow per Share |
1.51 | 2.93 | 2.79 | 0.38 | 3.99 | 3.08 | 2.01 | 1.26 | (0.15) | 0.57 |
Cash per Share |
4.28 | 8.02 | 10.35 | 7.44 | 8.03 | 11.41 | 3.07 | 1.71 | 0.87 | 1.51 |
Shareholders Equity per Share |
26.80 | 27.00 | 26.30 | 25.45 | 26.38 | 22.72 | 20.39 | 17.32 | 14.79 | 11.94 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
26.80 | 27.00 | 26.30 | 25.45 | 26.38 | 22.72 | 20.39 | 17.32 | 14.79 | 11.94 |
Free Cash Flow |
69.37 | 134.93 | 126.08 | 17.04 | 173.47 | 131.00 | 83.34 | 49.59 | (5.71) | 20.74 |
Working Capital |
203.46 | 219.82 | 559.78 | 453.37 | (95.46) | 552.99 | 246.24 | 192.55 | 147.07 | 134.50 |
Capital Expenditures |
(57.93) | (52.79) | (55.02) | (60.74) | (58.33) | (54.87) | (61.66) | (54.37) | (30.54) | (29.16) |
Net Current Asset Value |
(62.84) | (62.15) | (110.35) | (198.81) | (215.10) | (27.59) | 87.68 | (4.49) | (109.75) | (188.09) |
EV/EBIT |
431.81 | 5,998.61 | 0.00 | 0.00 | 89.64 | 143.67 | 42.39 | 56.07 | 182.42 | 67.43 |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 | 0.04 | 0.04 |
Price to Operating Income |
403.54 | 6,084.93 | 0.00 | 0.00 | 87.64 | 143.86 | 43.24 | 54.14 | 166.48 | 58.11 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.74 | 0.83 | 0.92 | 1.10 | 1.50 | 1.32 | 1.22 | 1.04 | 1.25 | 1.43 |
Cash ROIC |
4.35% | 6.91% | 5.66% | 0.84% | 8.57% | 6.78% | 8.07% | 5.62% | (0.72%) | 2.80% |
Accounts Receivable Turnover |
5.01 | 4.38 | 4.16 | 4.80 | 5.25 | 4.37 | 4.33 | 4.08 | 4.19 | 5.39 |
Accounts Payable Turnover |
14.23 | 13.25 | 12.00 | 10.48 | 10.33 | 11.05 | 10.90 | 9.61 | 10.46 | 15.24 |
Inventory Turnover |
7.19 | 6.45 | 5.05 | 5.29 | 5.34 | 4.69 | 4.41 | 4.21 | 4.76 | 6.54 |
Average Days of Payables |
23.56 | 29.48 | 25.27 | 32.73 | 45.21 | 30.72 | 36.79 | 33.46 | 44.73 | 26.08 |
Days of Inventory on Hand |
54.05 | 50.47 | 61.80 | 76.18 | 75.81 | 73.39 | 85.68 | 88.72 | 89.04 | 66.77 |
Average Receivables |
236.63 | 254.21 | 275.75 | 270.18 | 215.51 | 204.24 | 207.30 | 193.14 | 170.17 | 129.13 |
Average Payables |
47.89 | 48.41 | 54.21 | 67.45 | 55.91 | 43.34 | 42.21 | 43.16 | 37.68 | 24.86 |
Average Inventory |
94.78 | 99.38 | 128.82 | 133.74 | 108.11 | 102.15 | 104.44 | 98.50 | 82.72 | 57.95 |
Average Assets |
2,047.84 | 2,173.92 | 2,218.82 | 2,176.63 | 1,983.50 | 1,532.66 | 1,161.03 | 1,048.80 | 975.73 | 756.93 |
Average Common Equity |
1,237.56 | 1,216.13 | 1,159.55 | 1,138.41 | 1,057.10 | 906.38 | 762.44 | 616.98 | 492.97 | 417.00 |
Columns are period end dates